Skip to content
After two decades of research and development, Sutro Biopharma is still a few years away from seeking market approval for its first drug, a […]
Loss of tax incentive for R&D threatens biotech innovation Read More »
Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two
FDA approves CRISPR-based sickle cell treatment in historic decision Read More »
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the
BIO names John F. Crowley as new President & CEO Read More »
Did you know that every 10 minutes, a new person is added to the organ transplant waiting list? According to the United Network for
How X-Therma is stopping the clock – and fundamentally changing organ transplantation Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
Dr. Mary-Ann Etiebet, Associate Vice President, Health Equity, Merck, has more than two decades of experience working across the public and private sectors to
Turning insights into action: building a U.S. health system that delivers for all women Read More »
The only constant is change. The trick for entrepreneurs and investors, it would seem, is to map and anticipate that change and operate with
What investors look for in early-stage companies Read More »
Indiana Governor Eric Holcomb was named Governor of the Year for 2023, an award presented by the Biotechnology Innovation Organization (BIO) to recognize governors’
Indiana’s Eric Holcomb named Governor of the Year Read More »
Women’s health has long been an underserved area when it comes to clinical innovation, R&D, and funding—the Women’s Health Innovation Opportunity Map (WHOM) is
Women’s Health Innovation Opportunity Map launches Read More »
Biotech was front and center as Biotechnology Innovation Organization (BIO) CEO Rachel King met with Maryland Governor Wes Moore at the University of Maryland
BIO CEO meets Maryland Governor to highlight state’s vital relationship with biotech Read More »
